Sheng et al. revealed that p53 directly binds to the promoter of ST7-AS1 and activates ST7-AS1 expression at the transcriptional level, which subsequently binds PTBP1 to suppress Wnt/β-catenin signaling and inhibits GBM progression (Sheng et al., 2021). Here, ST7 is linked to glioblastoma.